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Background: Two-partner secretion systems in Gram-negative bacteria consist of an outer membrane protein TpsB
that mediates the secretion of a cognate TpsA protein into the extracellular milieu. TpsA proteins have diverse,
often virulence-related functions, and some of them inhibit the growth of related bacteria. In Neisseria meningitidis,
several functions have been attributed to the TpsA proteins. Downstream of the tpsB and tpsA genes, several
shorter tpsA-related gene cassettes, called tpsC, are located interspersed with intervening open-reading frames
(IORFs). It has been suggested that the tpsC cassettes may recombine with the tpsA gene as a mechanism of
antigenic variation. Here, we investigated (i) whether TpsA of N. meningitidis also has growth-inhibitory properties,
(ii) whether tpsC cassettes recombine with the tpsA gene, and (iii) what the consequences of such recombination
events might be.
Results: We demonstrate that meningococcal TpsA has growth-inhibitory properties and that the IORF located
immediately downstream of tpsA confers immunity to the producing strain. Although bioinformatics analysis
suggests that recombination between tpsC cassettes and tpsA occurs, detailed analysis of the tpsA gene in a large
collection of disease isolates of three clonal complexes revealed that the frequency is very low and cannot be a
mechanism of antigenic variation. However, recombination affected growth inhibition. In vitro experiments revealed
that recombination can be mediated through acquirement of tpsC cassettes from the environment and it identified
the regions involved in the recombination.
Conclusions: Meningococcal TpsA has growth-inhibitory properties. Recombination between tpsA and tpsC
cassettes occurs in vivo but is rare and has consequences for growth inhibition. A recombination model is
proposed and we propose that the main goal of recombination is the collection of new IORFs for protection
against a variety of TpsA proteins.
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Interstrain competitionBackground
Neisseria meningitidis is a Gram-negative bacterium that
colonizes the human respiratory tract and occasionally
causes meningitis and/or sepsis. Disease-related strains
can express either one of six different capsular polysac-
charides (A, B, C, Y, W135 and X). Polysaccharide-based
vaccines have been developed against four of these
capsule types. Unfortunately, the serogroup B capsular* Correspondence: J.A.arenasbusto@uu.nl
1Department of Molecular Microbiology, Utrecht University, Padualaan 8,
Utrecht 3584 CH, The Netherlands
Full list of author information is available at the end of the article
© 2013 Arenas et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orpolysaccharide cannot be used as a vaccine due to its
poor immunogenicity, while non-capsular antigens seem
to be effective only temporarily and in specific geo-
graphic areas due to high antigenic variability in
meningococci.
Various outer-membrane components and secreted
proteins exhibit variable expression and/or antigenic di-
versity, which plays an important role in immune escape
and has serious implications for the development of ef-
fective vaccines [1]. The high variability of these antigens
is based on different mechanisms, including gene con-
version and slipped-strand mispairing [2].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Comparison of the genetic organization of three TPS
islands in different meningococcal strains. Each island consists
from the 5’ to the 3’ end of a tpsB, a tpsA, and a variable number of
tpsC cassettes interspersed with intervening ORFs (IORFs) (open
arrows). The tpsA genes and tpsC cassettes can display very different
domains of ~450 bp at their 3’ end as indicated by the different
colors. Domains with very high sequence similarity are indicated
with the same color. Also the IORFs show high heterogeneity and
IORFs with high sequence similarity are indicated with the same
color. Note that tpsA or tpsC genes with similar sequences at their 3’
end are always followed by IORFs with high sequence similarity.
Regions with high sequence similarity between the different islands
are indicated by grey shading, indicating gross rearrangements in
the organization between the islands. Note that strain MC58
contains five tpsA genes, including two tpsA genes of system 1
(Figure S1 in Additional file 1). The island depicted here contains the
tpsA1b gene with locus tag NMB0497.
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DNA fragments situated at different chromosomal loca-
tions. It is based upon homologous recombination
between the donor and recipient loci [3,4]. Virulence-
associated surface structures in bacterial pathogens are
often subject to antigenic variation by gene conversion.
This has been studied extensively for the pilin locus
of Neisseria spp. [5-7]. The retractile type IV pili of
Neisseria are involved in attachment to host tissues
[8,9], DNA acquisition [10,11] and twitching motility
[12]. In addition to the pilin expression locus pilE, the
genome of these bacteria contains a repertoire of
promoter-less pilS cassettes, with homologous and vari-
able regions relative to pilE. These pilS cassettes can
unidirectionally be transferred to the pilE expression
locus, resulting in partial alteration of the pilin sequence.
Alternatively, this recombination event can switch off
the formation of pili by introduction of a premature stop
codon in pilE. The frequency of gene conversion seems
to be strain and species dependent and can be as high as
0.13 recombination events per cell in the case of gono-
coccal strain FA1090 [13].
In two-partner secretion (TPS) systems, a large pro-
tein, generically called TpsA, is secreted through a spe-
cific outer membrane transporter, designated TpsB
[14,15]. TpsA is synthesized as a precursor with a signal
sequence and transported to the periplasm via the Sec
machinery. In the periplasm, it interacts via its N-
terminally located TPS domain with TpsB and is
transported to the cell surface. TPS systems of N.
meningitidis seem of relevance to pathogenicity as sug-
gested by reported roles in adhesion [16], intracellular
survival [17] and biofilm formation [18]. Cluster analysis
of the sequences of the TpsB proteins and of the TPS
domains of the TpsA proteins revealed the presence
of three different TPS systems in N. meningitidis [19].
Different isolates of N. meningitidis can contain one to
three different TPS systems, and some of these systems
can contain two tpsA genes [19]. In the genome se-
quence of strain MC58, for example, five different tpsA
genes were identified, two of system 1 (designated
tpsA1a and tpsA1b), two of system 2 (tpsA2a and
tpsA2b), and one of system 3 (tpsA3). In contrast, the
genome sequences of strains FAM18, 053442 and Z2491
contain only one single tpsA, i.e. a tpsA of system 1
(tpsA1 a.k.a. hrpA) [19-21], which appears most wide-
spread among meningococcal isolates [19]. The tpsB and
tpsA genes are situated on specific genetic islands on the
chromosome. Downstream of the tpsA genes, several
tpsA-related open reading frames (ORFs) are located,
generically referred to as tpsC cassettes [21], inter-
spersed with small intervening ORFs (IORFs) (see
Figure 1 for examples). As compared to tpsA, all tpsC
cassettes are missing extensive portions at the 5’ endincluding the segment encoding the signal sequence and
the TPS domain. They do share sequence similarity with a
central part of tpsA but show an entirely different 3’ ter-
minal sequence [21]. From this observation, it was postu-
lated that these tpsC cassettes could substitute the 3’ end
of tpsA by gene conversion, thereby causing antigenic
variation of TpsA, similarly as in the pilE/S system [2,21].
Recently, Aoki et al. described that certain TpsA pro-
teins of E. coli inhibit the growth of related bacteria
[22,23]. This activity is mediated by direct contact be-
tween bacteria of the same species through the inter-
action of TpsA with the conserved outer membrane
protein BamA in the target cells [24]. The activity, re-
ferred to as contact-dependent growth inhibition (CDI),
was also observed in other bacteria [22,25].The CDI ac-
tivity resides in the C-terminal region of TpsA, which is
cleaved off from TpsA after interaction with the receptor
and delivered in the cytoplasm of target cells, where it
exerts DNase or tRNase activity. Immunity in the produ-
cing cells is provided by a small protein encoded by the
ORF immediately downstream of tpsA. This immunity
protein binds the toxic domain of TpsA and inhibits
its activity [22]. Like in the tps gene clusters of N.
meningitidis, these tpsA genes are often followed by
several 5’-truncated tpsA homologs displaying entirely
different 3’ ends [26]. It was proposed that these tpsCs
comprise a reservoir of alternative C-terminal regions
and that exchange of the 3’ end of tpsA by a tpsC
cassette alters the CDI mechanism [26]. However, so far,
no study addressed whether such substitutions at the 3’
end of tpsA actually take place.
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the meningococcal TpsA proteins mediate growth inhib-
ition. Then, we investigated whether recombination at
the 3’ end of tpsA indeed occurs in vivo and what the
frequency, the mechanism, and the function of such
recombination might be.
Results
Meningococcal TpsA1 mediates growth inhibition
To investigate whether meningococcal TpsA proteins
may possess growth-inhibitory activity, we initially fo-
cused on strain FAM18, which contains a single TPS
island with one tpsA1 gene and five tpsC cassettes
(Figure 1) [2,20]. However, since this strain appeared
non-transformable, we switched to strain B16B6, another
reference strain of the same clonal complex (cc), i.e.
cc11. Sequencing of the complete TPS island of strain
B16B6 (Genbank: HQ420265) revealed exactly the same
genetic organization and > 99% sequence identity at the
nucleotide level with that of FAM18. The TpsA protein
of B16B6 shows only three amino-acid substitutions
relative to that of FAM18.
Next, we constructed a ΔtpsA-tpsC mutant of strain
B16B6 lacking tpsA and all tpsC cassettes and IORFs. In
addition, since the presence of a capsule inhibits CDI in
E. coli [22], we used capsule-deficient derivatives in all
assays described below. When we co-incubated the wild
type and the ΔtpsA-tpsC mutant in liquid medium as
described for E. coli [23], no growth inhibition of the
mutant was observed independent of the media used
(TSB, LB, or RPMI), co-incubation time (3–6 hours) or
initial ratio of target and killer cells (ranging from 1:1 to
1:1000). It has been reported that meningococcal TpsA
affects later stages of biofilm development (48 hours old
biofilms) and that its production is increased under
anaerobic conditions [18]. Thus, we co-incubated the
wild type and the mutant on agar plates in a candle jar
with low oxygen concentrations. Under these conditions,
growth inhibition of the mutant was observed as a de-
cline in time of the ratio of the colony-forming units
(CFU) of the mutant over that of the wild type
(Figure 2A, grey bars). In contrast, growth of a ΔtpsB
mutant, which is defective in the secretion of TpsA but
still contains all IORFs, was not affected when co-
incubated with the wild type (Figure 2A, white bars).
Also, growth of a ΔtpsC2-5 mutant, which lacks tpsC2 to
tpsC6 and the IORFs in between, but still contains IORF1
and IORF2, was not affected when co-incubated with the
wild type (Figure 2A, hatched bars), suggesting that pro-
tection against the growth-inhibiting properties of TpsA
is mediated by IORF1 and/or IORF2.
To confirm the role of the IORF1 immediately down-
stream of tpsA in B16B6 in conferring immunity, the
corresponding gene was cloned behind an isopropyl-β-D-1-thiogalactopyranoside (IPTG)-inducible promoter
on plasmid and introduced into the ΔtpsA-tpsC mutant.
Growth of the complemented strain was inhibited when
co-incubated with the wild-type strain in the absence
but not in the presence of IPTG (Figure 2B). Thus, the
IORF indeed confers immunity to growth inhibition me-
diated by TpsA. In conclusion, the meningococcal TpsA
protein has growth-inhibitory activity and the IORF im-
mediately downstream of tpsA provides immunity to this
activity.
Structural organization of meningococcal TpsA1 and TpsC
proteins
To study possible genetic exchange between tpsA genes
and tpsC cassettes, we first extended previous bioinfor-
matic analyses using available genome sequences [19,21],
thereby focusing on TPS system 1 because of its wide-
spread presence in meningococcal isolates. The genetic
organization of TPS system 1 islands in the available
genome sequences of strains α14 [27], α153 [27], α275
[27], 053442 [28], 8013 [29], FAM18 [2], MC58 [30] and
Z2491 [31] is depicted in Figure S1 in Additional file 1
with selected examples shown in Figure 1.
Multiple sequence alignments of the corresponding
TpsA proteins (data not shown) revealed that they are
modular and consist of three regions: a highly conserved
N-terminal region, a semi-variable central region, and a
hyper-variable C-terminal region. The N-terminal region
of ~500 amino acids shows > 98% identity between all
aligned sequences and contains the TPS domain re-
quired for interaction with the TpsB protein in the outer
membrane. For the central region of ~900 amino-acid res-
idues, two main allelic variants were identified designated
core 1 and core 2 (Figure S2A in Additional file 1). These
sequences showed > 19% divergence between the groups
and < 2% divergence within the groups. The C-terminal
regions of ~600 amino-acid residues, where the toxic ac-
tivity of TpsA resides, are highly variable with sequence
divergence ranging from 5-50%. Sequence divergence is
particularly high in the last ~150 residues, where five
different groups of sequences can be discriminated among
the 10 TpsA proteins compared (Figure S2B in Additional
file 1). These C-terminal domains show very high
sequence conservation within the groups (> 98%) and
extremely low, if any, sequence similarity between
the groups.
The polypeptides putatively encoded by the tpsC cas-
settes are variable in length (260–893 residues). In their
N-terminal part upstream of a conserved VENN motif
(22), they share sequence similarity with TpsA proteins
(see Figure S3 in Additional file 1, which shows an align-
ment of the C-terminal region of TpsA and the putative
TpsC proteins of strain FAM18). The corresponding
DNA sequences are presumably used for homologous
Figure 2 Growth-inhibitory function of meningococcal TpsA. (A) Cells of an unencapsulated derivative of strain B16B6, carrying a plasmid
with a chloramphenicol-resistance marker, were mixed 1:1 with cells of ΔtpsA-tpsC, ΔtpsB or ΔtpsC2-5 mutants, all carrying a kan cassette. The
suspensions were spotted on GC plates without antibiotics and incubated for various time periods. In the experiment with the ΔtpsC2-5 mutant as
the target cells, the suspensions were only spotted after 0 and 48 hours. The ratios of the ΔtpsA-tpsC (grey bars), ΔtpsB (white bars), or ΔtpsC2-5
(hatched bars) mutants over wild-type bacteria in the spots was determined by plating on GC media containing kanamycin or chloramphenicol
and counting colony-forming units after overnight incubation. (B) A rifampicin-resistant derivative of the unencapsulated B16B6 strain was mixed
1:1 with the ΔtpsA-tpsC mutant harboring plasmid pFPIORF1, which contains the first IORF of B16B6 under the control of an IPTG-inducible
promoter. The bacteria were incubated in the presence or absence of IPTG for 24 hours as above. The ratio of the ΔtpsA-tpsC mutant over the
wild-type bacteria was determined as described. Results are means and s.d. of three independent experiments. All the strains tested here did not
show differences in viability when grown separately.
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VENN motif and particularly within the C-terminal moi-
eties of ~150 amino-acid residues, the sequences are
again hyper-variable (Figure S3 in Additional file 1),
some sharing high sequence similarity with C-terminal
segments of TpsA proteins and others constituting new
groups of C-terminal domains. Sequence comparisons
identified 11 different groups of TpsA/TpsC C-terminal
sequences (indicated by different colors in Figure 1 and
Figure S1 in Additional file 1) with > 90% of similarity
within the groups (Additional file 1: Table S1). The
results of such sequence analyses are consistent with the
occurrence in vivo of the suggested gene conversion at
the 3’ end of the tpsA gene [21]. For example, the tpsAof strain Z2491 could have been generated by recombin-
ation of a tpsC cassette similar to tpsC3 of strain FAM18
into a tpsA like NMB0497 of MC58 (Figure 1). However,
it should be noted that also recombination mechanisms
other than gene conversion could be responsible for the
observed variation in the 3’ end of tpsA.
The polypeptides encoded by the IORFs located in be-
tween tpsA and tpsCs (open arrows in Additional file 1:
Figure 1 and Figure S1) putatively encode immunity pro-
teins to confer protection against the toxic activity of the
products of the directly upstream located tpsA or tpsC.
They can be grouped with > 95% sequence similarity
within the groups and very low, if any, similarity be-
tween the groups (data not shown). Interestingly, tpsAs
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immediately followed by an IORF from the same se-
quence group. IORFs of the same group are colored
identically in Figure 1 and Figure S1 in Additional file 1,
and, to reflect the interconnectivity with the upstream
TpsA/TpsC, the same color is used for the IORFs as for
the C-terminal ends of the upstream TpsA or TpsC.
Replacement of the 3’ end of tpsA is rare in cc11 and cc8
strains
The bioinformatic analysis above is consistent with the
occurrence of the suggested gene conversion at the 3’
end of meningococcal tpsA. However, the TPS islands in
the strains analyzed could also have been acquired inde-
pendently by horizontal gene transfer from different
sources. To determine whether recombination of tpsC
cassettes with the 3’ end of tpsA indeed occurs in vivo,
we decided to analyze the TPS system 1 of various iso-
lates from the same cc. If recombination indeed takes
place at frequencies comparable, for example, to that
reported for gene conversion at the pilE locus, different
tpsC cassettes would be expected to be present at the C
terminus of TpsA in such isolates. For this purpose, we
first focused on cc11, a lineage predominantly associated
with invasive disease [32] and therefore useful to evalu-
ate the possible implications of such recombination
events during human infection.
The observation that the organization of the TPS island
of B16B6 is very similar to that of FAM18 (see above) in
spite of the very different isolation years of these strains
being 23 years apart (Additional file 2) already suggested
that the tps loci might actually be rather stable. We then
decided to analyze a large panel of 277 cc11 disease iso-
lates collected in The Netherlands between 1960 and 2008
(Additional file 2). We used PCR to assess for possible re-
placements of the 3’ end of tpsA by tpsC cassettes as
outlined in detail in Figure S4 in Additional file 1; the re-
sults for individual isolates are listed in Additional file 2:
Table S2. With only three exceptions, which are described
in detail in the next section, all isolates showed the pres-
ence of the same cassette at the 3’ end of tpsA as in
FAM18. These results demonstrate that the tpsA locus in
cc11 strains is remarkably stable. A possible explanation
for the observed stability of tpsA is that the cassette
present at the C terminus of TpsA in cc11 isolates is
maintained because it is required for the highly invasive
phenotype of these strains or because of reduced
interbacterial competition during infection. To investigate
this possibility, we also analyzed six cc11 carrier isolates
using similar procedures (Figure S4 in Additional file 1),
which revealed again the same organization as that in
FAM18, suggesting that the 3’ end of tpsA is also stably
maintained in these isolates and that the lack of exchange
is not favored by host invasion.For comparison, we determined the frequency of an-
other well-known mechanism of genetic variation, i.e.
phase-variation by slipped-strand mispairing at direct
DNA repeats, in cc11 strains. Thus, the expression of
the autotransporter NalP and the outer membrane Opa
proteins, which both exhibit phase-variable expression
[33,34], was evaluated by Western blotting in a panel of
56 cc11 isolates, including both carrier and disease iso-
lates (Additional file 2: Table S2). Of these isolates, 32
were positive for NalP expression (57%) and 23 for Opa
expression (41%). Thus, the frequency of recombination
at the 3’ end of the tpsA gene is clearly much lower than
that of another genetic mechanism of variation used by
this pathogen during infection.
Finally, we analyzed strains from another hyperinvasive
cc, i.e. cc8, using the same strategy. The TPS island of cc8
strain NMB was recently reported to have a similar
organization as that in FAM18 [18]. We sequenced tpsA of
another cc8 strain, strain 2996 (Genbank: HQ420264), and
found 99% identity at the nucleotide level with tpsA of
FAM18. PCR analysis targeted for various fragments in the
downstream region (Figure S4 in Additional file 1) indi-
cated the same organization of tpsCs as in FAM18. Next, a
panel of 91 cc8 disease isolates was analyzed (Figure S4 in
Additional file 1); all of them appeared to contain the same
cassette at the 3’ end of tpsA as in FAM18. Thus, recom-
bination at the 3’ end of the tpsA locus did not occur in the
isolates examined and is therefore rare, also in cc8 strains.
Characterization of the TPS island in the deviating cc11
isolates
The three cc11 isolates that, according to the PCR ana-
lysis, deviated from FAM18 at the 3’ end of tpsA, i.e. iso-
lates 2001044, 2020041 and 348 (Additional file 2), all
produced a TpsA as evidenced by Western blotting (data
not shown). Further PCR analysis of the TPS island of
isolates 2001044 and 2020041 (Figure S4 in additional
file 1) indicated that the tpsC1 cassette had recombined
into the tpsA locus with loss of the intervening DNA as
depicted in Figure 3A. Sequence analysis of the entire
TPS island of isolate 2001044 (Genbank: HQ420262)
confirmed this suggestion. Of note, tpsC1 of FAM18
shows 99% sequence identity between bp 195–1628
with a segment of tpsA (bp 4218–5651) (Figure S5A in
Additional file 1). Comparison of the upstream and
downstream sequences indicated that the recombination
resulting in the tpsA of isolate 2001044 had occurred in
this shared region. The sequence downstream of tpsA in
isolate 2001044 showed > 99% identity with the region
downstream of tpsC1 in FAM18 (Figure 3A). This region
was also similar in isolate 2020041 (data not shown).
Thus, the results for these isolates demonstrate that re-
placement of the 3’ end of tpsA by tpsC cassettes indeed
occurs in vivo, albeit at a very low frequency.
Figure 3 Genetic organization of the deviant TPS organization in cc11 isolates 2001044 and 348 and consequences in growth-inhibition
activity. (A) Comparison of the TPS organization in cc11 reference strain FAM18 and the clinical isolate 2001044. (B) Comparison of the genetic
organization of the TPS island in clinical isolate 348 and those in cc11 reference strain FAM18 and cc4 reference strain Z2491. In both panels, regions of
high sequence similarity between the islands are indicated by grey shading. Note that the TPS organization in isolate 2001044 could have been
generated by intragenomic recombination, whilst that in isolate 348 must have implicated horizontal gene transfer. (C) Unencapsulated derivatives of
strains B16B6 and its ΔtpsA-tpsC mutant, both carrying an erythromycin-resistance marker, were mixed 1:1 with an unencapsulated derivative of strain
2001044 carrying a chloramphenicol-resistance marker, spotted on GC plates and incubated as described in the legend to Figure 2. The ratios of
2001044 bacteria over B16B6 (left) or B16B6ΔtpsA-tpsC mutant (right) bacteria were determined after 0 hours (gray bars) or 24 hours (white bars) of
incubation by plating on GC media containing erythromycin or chloramphenicol.
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the third deviant cc11 strain, isolate 348 (Genbank:
HQ420263), revealed more complex rearrangements
(Figure 3B). The encoded TpsA has a central core 2
region like in strain Z2491 instead of a core 1 as in
FAM18 (Figure S2A in Additional file 1), and it contains
a C terminal end identical to that of TpsC1 of Z2491
(Figure 3B). Thus, compared to Z2491, the 3’ end of
tpsA is replaced by tpsC1 in isolate 348. Sequence com-
parisons (Figure S5B) suggest that the recombination
event took place between bp 4174–4605 of tpsA and bp
910–1341 of tpsC1, where these sequences show high
sequence identity.
The IORF downstream of tpsA in isolate 348 is identi-
cal to that downstream of tpsC1 of Z2491 (Figure 3B).
The subsequent tpsC1 in 348 showed 94% identity
within the first 858 bp with the corresponding 5’ frag-
ment of tpsC2 of Z2491 (Figure 3B and Figure S5C in
Additional file 1). The rest of this tpsC1 was identical to
the 3’ end of tpsC1 of FAM18 (Figure 3B and Figure
S5C in Additional file 1), differing only in one single bp.
At the boundary, an 18-bp sequence is shared betweenthe three genes (Figure S5D in Additional file 1), which
was likely involved in the recombination event; appar-
ently, only short stretches of 100% identity are required
for this. The remaining part of the TPS island of isolate
348 showed > 99% identity with the corresponding
region of FAM18 (Figure 3B). Thus, it appears that the
tpsA of isolate 348 was generated by recombination
between a tpsA and a tpsC1similar to those of Z2491.
This tpsA gene was then introduced in the cc11 strain
by recombination at the 5’ end in the DNA encoding the
TPS domain of tpsA or in tpsB and at the 3’ end within
tpsC1.
A possible explanation for the low frequency of re-
combination observed at the 3’ end of tpsA in vivo is
that such recombination results in the concomitant loss
of the downstream IORF, which provides immunity to
the TpsA of the parental strain. Thus, within a microbial
community such as a biofilm or a microcolony, the
growth of a recombinant would be inhibited by its con-
geners. To investigate whether recombination indeed
confers a growth disadvantage in the presence of a wild-
type strain, we performed growth-inhibition experiments
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The growth of the deviating isolate was drastically reduced
when co-cultured with B16B6 (Figure 3C, left bars), pre-
sumably because it is not protected against TpsA of
B16B6. The growth of strain 2001044 was not inhibited
when the strain was co-cultured with the ΔtpsA-tpsC mu-
tant of B16B6, which does not produce TpsA (Figure 3C,
right bars), demonstrating that the TpsA of strain B16B6
is responsible for the growth inhibition of isolate 2001044.
In the latter experiment (Figure 3C, right bars), rather
the growth of the ΔtpsA-tpsC mutant appeared to be
inhibited, indicating that the recombinant TpsA produced
by isolate 2001044 has growth-inhibitory activity against
which the ΔtpsA-tpsC mutant of B16B6 is not protected
presumably because it lacks all immunity proteins includ-
ing that encoded by the IORF immediately downstream of
the tpsC1 cassette. Consistent with this notion is the ob-
servation that the growth of the ΔtpsB mutant of B16B6,
which does not secrete TpsA but has retained all IORFs,
was not inhibited by isolate 2001044 (data not shown). To
further confirm that the growth of isolate 2001044 is
inhibited in the presence of B16B6 because it lacks
the IORF immediately downstream of tpsA of B16B6
(Figure 3A), the strain was transformed with plasmid
pFPIORF1, which contains this IORF under lac promoter
control, and competition experiments with B16B6 were
performed in the presence or absence of IPTG. The
growth inhibition of the plasmid-containing 2001044 tar-
get cells was reduced by 3.1 log units (mean of three inde-
pendent experiments) in the presence as compared to the
absence of IPTG. Together, these data support the hypoth-
esis that recombination at the tpsA locus confers a select-
ive disadvantage within a genetically similar community
because of the loss of the relevant immunity protein.
Comparison of the frequency of exchange at the pilE and
tpsA loci
The results described above confirmed that the 3’ end of
tpsA can be replaced by tpsC cassettes in vivo but at a
much lower frequency than anticipated considering the
reported high frequency of recombination at the pilE
locus. However, it was reported recently that also gene
conversion at the pilE locus is not detectable in cc8 and
cc11 isolates [35,36]. Although this can be explained by
the nature of the pilE and pilS genes present in these
strains (vide infra), we cannot exclude the possibility
that cc8 and cc11 strains contain some additional gen-
etic defect that reduces the recombination frequency
also at the tpsA locus. To rule out this possibility, we
analyzed another clonal lineage, which is known to be
proficient in recombination at the pilE locus, i.e. cc32
[35], even though this analysis is more complicated by
the presence of two tpsA1 copies in strains of this cc,
such as MC58 (Additional file 1: Figure S1).We examined 50 cc32 disease isolates. First, the region
corresponding to the pilE locus was amplified by PCR as
described [35]. Three isolates did not yield an amplicon,
suggestive of loss of the pilE locus, whilst two yielded a
smaller amplicon than expected suggesting recombin-
ation with a pilS (Additional file 2). In a subsequent
PCR, one of the primers annealed to a variable region in
pilE. Of the 47 isolates positive for pilE, 13 did not yield
an amplicon in this PCR (Additional file 2), demonstrat-
ing recombination relative to the pilE sequence of MC58
in at least 28% of the strains.
Next, recombination at the tpsA1 loci was examined
by PCR as outlined in detail in Additional file 1: Figure
S6. This analysis revealed that the tpsA1b locus corre-
sponding to NMB0497 of strain MC58 was stably
maintained in all isolates. However, the tpsA1a locus
corresponding to NMB1779 was detected in the initial
PCR in only 37/50 isolates suggesting that either recom-
bination had occurred at this tpsA1 locus in the
remaining 13 isolates or the tpsA1 locus was not dupli-
cated in these isolates. Subsequent PCRs targeting the
boundaries of the TPS islands (Additional file 1: Figure
S6) revealed the absence of the duplication in 11 of these
isolates. In the remaining two isolates, the duplication
was detected and thus, apparently, recombination
had occurred at the tpsA1a locus. Subsequent PCRs
(outlined in Figure S6 in Additional file 1) revealed the
presence in one of these isolates of a tpsA1 similar to
that of FAM18, i.e. with a central core different from
that of the tpsA1 genes of MC58. Therefore, this tpsA1
must have been acquired in this isolate by horizontal
gene transfer. In the other isolate, we detected that the
tpsC5 located downstream of tpsA1b had recombined
into the tpsA1a locus (Figure S6 in Additional file 1).
Thus, in 50 isolates containing in total 89 tpsA1 genes,
only a single case of tpsA/C exchange was detected (i.e.
1.1%), in agreement with the low frequency detected in
cc11 and cc8 isolates and much lower than the fre-
quency of gene conversion at the pilE locus in the same
set of strains. Consistent with our results, also in the
newly available genome sequence of cc32 isolate H44/76
[37], the organization of the tpsA1-containing islands is
similar to that in MC58 whilst the pilE gene is different.
Recombination within TPS sequences under laboratory
conditions
One of the models for gene conversion at the pilE locus
implicates the acquisition of pilS sequences from the en-
vironment [38]. Hence, we investigated whether we
could induce recombination at the 3’ end of tpsA by
exogenously supplying tpsC cassettes. In preliminary
experiments, we incubated purified chromosomal DNA
from strain B16B6 with the homologous (B16B6) or
heterologous (α153 and α14) strains. PCR analysis of
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recombination at the 3’ end of tpsA (data not shown),
indicating that such events are rare consistent with the
low recombination frequencies found in vivo. Then, a
kanamycin-resistance (kan) cassette was inserted be-
tween the 5’ end of tpsC2 and the 3’ end of the TPS
island (Figure 4A). When chromosomal DNA of the
resulting mutant, designated B16B6ΔtpsC2-5, was used
to transform the parent strain B16B6, the kan cassette
was found at the same position as in the original mutant
in all 150 transformants examined as evidenced by
PCRs. Apparently, the high sequence identity at either
side of the kan cassette forces reciprocal exchange by
homologous recombination. When strain α14 was
transformed, recombination had occurred within the 5’
region of the disrupted tpsC2 cassette of the donor DNA
and the tpsA gene in the recipient DNA in all 19
kanamycin-resistant transformants examined as revealed
in PCRs and subsequent sequence analysis (Figure 4B).
Recombination in the various transformants had taken
place at a variety of small stretches of sequence identity
ranging in size from 5 to 23 bp (Figure S7 in Additional
file 1). These results demonstrate that tpsC sequences
can recombine into the 3’ end of a tpsA gene when
exogenously supplied and that recombination does not
occur at a specific site but can take place at any short
stretch of sequence identity within a homologous region.
Next, chromosomal DNA from one of the α14-tpsA*
recombinants (#1 in Additional file 1: Figure S7) was
used to transform strain α153, which has a differentFigure 4 In vitro recombination in the TPS islands. (A) Organization of
5 where a kan cassette replaces several tpsC cassettes and IORFs. (B) Organ
obtained after transformation of strain α14 (top) with chromosomal DNA fr
in recombinant strain α153-tpsA* (middle) obtained after transformation of
(bottom). The organization of the TPS island of strain α153 is not complete
genome sequence.central core region in the tpsA gene (in Additional file 1:
Figure S2). Two kanamycin-resistant transformants were
obtained and PCR analysis and subsequent sequencing
(data not shown) revealed that the disrupted tpsA of the
donor DNA had recombined into the TPS island of α153
(Figure 4C). Thus, not only can tpsC cassettes recom-
bine into the 3’ region of tpsA genes but also the central
region of the tpsA gene can be replaced as was observed
in vivo in the case of cc11 isolate 348.
Discussion
TpsA1 proteins of N. meningitidis have reported roles in
adhesion [16], intracellular survival [17] and biofilm for-
mation [18]. In several other bacteria, TpsA proteins
have been described that inhibit the growth of related
bacteria probably in competition for the same niche
[22,23,25,26]. This CDI activity resides in the C-terminal
domain, and an immunity protein encoded by the gene
downstream of tpsA protects the producing strain. To-
gether, the C-terminal domain of TpsA and the immun-
ity protein function as a toxin/antitoxin pair. We
demonstrated here that also the TpsA1 proteins of N.
meningitidis have growth-inhibitory activity and that the
IORF immediately downstream of the tpsA gene confers
immunity.
Downstream of the tpsA gene, the TPS islands of N.
meningitidis contain a variable number of putative
genes, called tpsC cassettes, interspersed with IORFs.
The tpsC cassettes putatively encode N-terminally trun-
cated TpsA homologs, which present entirely differentthe TPS islands in strain B16B6 and its mutant derivative B16B6ΔtpsC2-
ization of the TPS island in recombinant strain α14-tpsA* (middle)
om strain B16B6ΔtpsC2-5 (bottom). (C) Organization of the TPS island
strain α153 (top) with chromosomal DNA from strain α14-tpsA*#1
ly depicted because it is not located on a single contig in the available
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cassettes could recombine with tpsA by gene conversion
possibly as a mechanism of immune evasion [19-21,31].
Also in several toxin/antitoxin systems, silent genes en-
coding truncated toxins are present and it was suggested
that recombination of these silent genes with the toxin
gene alters the CDI mechanism [26]. However, up to
date no direct experimental evidence for such recombin-
ation events has been reported.
Initial bioinformatic analysis indeed suggested exten-
sive recombination between tpsA genes and tpsC cas-
settes, as many cases were found of sequences that are
present at the 3’ end of a tpsC cassette in one genome
and at the 3’ end of a tpsA gene in another genome
(Figure 1, and Additional file 1: Figure S1 and Table S1).
However, because of the different phylogenetic origins of
these strains, these observations do not directly prove
that recombination does occur in vivo. Therefore, to
demonstrate that the expected recombination events in-
deed occur and to determine their frequency, we turned
to the analysis of large collections of strains of the same
clonal complexes. Initially, we focused on strains of cc11
and cc8, and we obtained evidence that tpsC cassettes
can indeed recombine in vivo into the tpsA locus, but
the observed frequency was dramatically lower than
the frequency of antigenic variation by slipped-strand
mispairing of other surface structures in the same collec-
tion of strains. In cc8 and cc11 isolates, gene conversion
at the pilE locus is not detectable either [35,36]. This is,
however, not due to a general recombination defect also
affecting the tpsA locus but to the nature of the pilE and
pilS genes present in these strains. N. meningitidis
strains can elaborate one of two classes of pili. Whereas
class I pili are closely related to gonococcal pili, class II
pili present remarkably different features, i.e. lack of
conserved regions in between the semi- and hyper-
variable regions, deletion in a hyper-variable region, and
no homology to class I pili in the flanking sequences
[39]. The cc8 and cc11 strains contain a class II pilE [35]
and the genome of FAM18 shows only two pilS cas-
settes, which exhibit strong homology to type-I pilin
genes [39]. Therefore, pilE/S recombination is not to be
expected and the low recombination frequency at the
tpsA locus must have a different cause. Consistent with
this hypothesis, we also found a very low frequency of
recombination in the tpsA locus in cc32 isolates, which
are proficient in recombination at pilE. Considering that
the strains we analyzed are from hyperinvasive lineages,
the low frequency of recombination at the 3’ end of tpsA
compared to known mechanisms of antigenic variation
suggests that the selection of new TpsA variants in vivo
is not driven by immune pressure. Also, although N.
meningitidis apparently has a large repertoire of alter-
nate cassettes that could replace the killing module atthe C terminus of TpsA, it apparently has only a low
tendency to change it. This suggests that replacement of
the C-terminal cassette of TpsA may even be detrimen-
tal to the bacteria. In the nasopharynx, N. meningitidis
appears in microcolonies [40]. Obviously, within such a
microcolony, the substitution of the C terminus of TpsA
with the concomitant loss of the immunity protein as
found in some cc11 isolates (Figure 3) would be detri-
mental as the protection against other cells within the
community would be lost.
Although the frequency is low, the postulated recom-
bination at the 3’ end of tpsA was confirmed both
in vivo and in vitro. Figure 5A illustrates a model for the
recombination mechanism as deduced from our work.
We postulate that the minimal recombination unit con-
sists of a tpsC, an IORF and the 5’ region of the next
tpsC. Homologous recombination occurs in the borders
of the recombination unit in the donor DNA with
equivalent sequences in the recipient DNA. During the
recombination event, a variable number of additional
tpsCs, together with their downstream IORFs, can be in-
corporated or lost in the recipient DNA, which may re-
sult in extensive modification of the tpsC repertoire and
may or may not alter the 3’ end of the tpsA gene. The
sequences of the IORFs located immediately down-
stream of tpsAs or tpsCs with similar 3’ ends are highly
conserved and show no sequence similarity with other
IORFs. In the recombination models, the IORFs always
remain associated with the upstream tpsC and will
therefore confer immunity to the producing strain when
this tpsC is recombined into the tpsA expression locus
(Figure 3). Besides this process, the central region of the
tpsA can also be replaced in which case the recombin-
ation at the 5’ end occurs within the DNA encoding the
TPS domain or in tpsB or even further upstream, and at
the 3’ end in the 5’ region of a downstream tpsC. No
functional activity has been assigned to this central core
region. Perhaps, it is only required for the efficient
secretion and surface exposure of the killing module.
However, considering its size and variability, it may serve
additional functions. Besides mediating growth inhib-
ition, meningococcal TpsA proteins are also involved in
adhesion [16], intracellular survival [17] and biofilm
formation [18]. Further experiments should clarify if the
core region has a direct role in these additional TpsA
activities.
Neisseria shows autolytic behavior and has the cap-
acity to take up Neisserial DNA fragments by recog-
nition of specific DNA uptake sequences [38]. The
acquisition of pilS sequences from the environment is
used for recombination of pilS to pilE [38,41]. The pres-
ence of DNA uptake sequences within the TPS islands,
mostly located at the 5’ end of tpsC cassettes (Additional
file 1: Figure S1), is consistent with the hypothesis that
Figure 5 (See legend on next page.)
Arenas et al. BMC Genomics 2013, 14:622 Page 10 of 14
http://www.biomedcentral.com/1471-2164/14/622
(See figure on previous page.)
Figure 5 Recombination model for the TPS system. (A) Recombination model requiring double crossover. The recipient and donor DNA are
indicated in the first and the second line, respectively, and carry in the depicted example a different central core region in tpsA. IORFs are not
depicted. Within the 3’ region, the tpsA genes share sequences with segments at the 5’ end of tpsCs (black boxes). The minimal recombination
units (indicated by double-headed arrows) are formed by the 5’ region of a tpsC, an IORF, and the 5’ region of the immediately downstream tpsC.
The recombination products show the recipient DNA organization after double crossovers with donor DNA sequences. The double-headed lines
show the recombination sites where the crossovers were established. (B) Recombination model requiring an intra-chromosomal single crossover
and the product of such an event evolved from the organization of the recipient DNA shown in the first line of panel A.
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from the medium. Our in vitro recombination studies
offer experimental support for this mechanism. Obvi-
ously, for exchange of the central core region of tpsA,
uptake of donor DNA from the environment is a neces-
sity. Another model explains pilE/S gene conversion
based on intracellular recombination substrates and as-
sumes that DNA replication producing two chromosomes
precedes recombination by double crossover [41,42]. Yet
another model implicates the generation of an extrachro-
mosomal circular intermediate generated by a single
crossover (Figure 5B) [42,43]. Both models could explain
the TPS organization in cc11 isolates in which the tpsC1
cassette has apparently recombined into the tpsA locus
(Figure 3A). It is interesting to note that tpsC5 of FAM18
is the most distal tpsC in many TPS regions (colored blue
in Figure S1in Additional file 1). The absence of a down-
stream tpsC cassette for establishing recombination may
prevent its movement to another position in the tpsC
repertoire. In the genome of strain α14, this tpsC has
recombined into the tpsA gene with concomitant loss of
all intervening tpsCs (Figure S1 in Additional file 1), which
can be explained through a single crossover recombin-
ation event. Thus, like in the pilE/pilS system [13], recom-
bination of tpsCs into the tpsA locus can be mediated by
three different mechanisms involving uptake of DNA from
the environment, recombination between sister chromo-
somes, or an intra-chromosomal single crossover event.
Where exactly the recombination between tpsA and
tpsC cassettes takes place, has remained unclear thus far.
Based on in silico analysis, it was previously predicted to
be mediated by multiple direct repeats located in the 3’
half of tpsA and the 5’ end of tpsCs [21]. In contrast, Poole
and colleagues suggested that these events take place at a
more specific location, i.e. the VENN domain that is
present in many tpsAs and tpsCs [26], including tpsA and
tpsCs of N. meningitidis (indicated in Additional file 1:
Figure S3 ). The results presented here show that the re-
combination can take place in small shared stretches of
different length (5 to 23 bp, in Additional file 1: Figure S7)
that are broadly distributed along a larger homology do-
main (in Additional file 1: Figure S3), in line with what
was reported in the pilE/S system [13].
Although the postulated recombination at the 3’ end
of TpsA was demonstrated in this study, the frequencywas very low. If the recombination frequency is that low
and recombination may even be detrimental, why have
most N. meningitidis isolates generated such a large col-
lection of tpsC cassettes? Possibly, the importance of the
collection is not in the tpsC cassettes, but in the associated
IORFs that, together, confer immunity to a large variety of
TpsAs produced by competitors in the nasopharynx. Con-
sistent with the proposed minor role of the tpsC cassettes
is that we detected many tpsCs with internal stop codons,
frameshift mutations or extensive truncations at the 3’ end
removing the homology domain for recombination into
the tpsA locus (Additional file 1: Table S1 and Figure S1).
Conclusions
Several TpsA proteins produced by Gram-negative bacteria
inhibit the growth of other related bacteria probably in com-
petition for the same niche. The toxic activity resides in
its C-terminal region while an immediately downstream lo-
cated IORF encodes an antitoxin protein. Here, we showed
that also meningococcal TpsA mediates growth inhibition
and that the downstream IORF confers immunity to the
producing strain. We also demonstrated that tpsC cassettes
can recombine into the tpsA locus leading to the presenta-
tion of a different toxic module at the C terminus of TpsA.
We obtained evidence for such recombination both in vivo
during infection and under laboratory conditions. However,
new TpsA variants are generated only at a very low fre-
quency possibly due to negative selection against recombin-
ation as consequence of the concomitant loss of the
immunity protein resulting in sensitivity to the TpsA protein
produced by the congeners in the same microbial commu-
nity. The tpsC cassettes for recombination can be acquired
from the environment and recombine into the tpsA gene
or in the downstream region, potentially resulting in an
increased or decreased number of tpsC cassettes and associ-
ated IORFs. We propose that the main goal of recom-
bination is the collection of new IORFs for protection
against a variety of TpsA proteins. Further studies on the
mechanisms of TpsA-mediated fratricide might eventually
enable us to fight these pathogens with their own weapons.
Methods
Bacterial strains and growth conditions
A panel of 424 N. meningitidis strains was examined
here (Additional file 2). Disease isolates were from The
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tis (NRLBM) in Amsterdam and carrier strains from the
Institut für Hygiene und Mikrobiologie, Würzburg. Iso-
lates were classified in clonal groups based upon se-
quence analysis of conserved house-keeping genes and
comparison of the results with the data on the Neisseria
Multi Locus Sequence Typing website (http://pubmlst.
org/neisseria/) [44]. Included in this study were also ref-
erence strains B16B6 [45], 2996 [46], FAM18 [2], α14
and α153 [27] (Additional file 2). Strains were grown at
37°C on GC medium (Oxoid) supplemented with Vitox
(Oxoid) and antibiotics as appropriate (erythromycin 7
μg/ml; kanamycin, 100 μg/ml; chloramphenicol, 5 μg/ml;
rifampicin, 50 μg/ml) in candle jars or in tryptic soy
broth (TSB; Beckton Dickinson) at 37°C with constant
shaking at 110 rpm for 7 to 8 hours. Bacteria were
inactivated for 30 minutes at 56°C when appropriate. E.
coli strain DH5α was grown in LB medium containing
100 μg/ml of kanamycin or ampicillin when required.
PCR amplification and sequencing
Bacteria, grown for 12 hours on plate, were resuspended
in de-ionized water and boiled for 10 minutes. The super-
natant obtained after removal of the cell debris by centri-
fugation was used as template DNA for PCRs [19]. PCRs
were performed using 2 μl of extracted DNA, 0.25 μM of
different primer combinations (Additional file 3), 0.5 U
Taq DNA polymerase, 200 μM dNTPs and PCR buffer (all
from Promega). For PCR products to be sequenced, the
Expand High Fidelity PCR System (Roche) was used. PCR
conditions consisted of 10 minutes incubation at 95°C, 30
cycles of 1 minute at 95°C, 0.5 minutes at 58°C, and 2.5
minutes at 72°C, and finally 10 minutes incubation at
72°C. The PCR products were analyzed on 1% agarose gels
and visualized with ethidium bromide.
For sequencing of the TPS islands, several overlapping
DNA fragments of variable length (568–2500 bp) were
amplified, purified using the Wizard SV Gel and PCR
Clean-Up System (Promega), and sequenced using in-
ternal primers at Macrogen (Seoul, Korea). When re-
quired, PCR products were cloned into the TOPO TA
vector (Invitrogen). The plasmids were purified with the
plasmid extraction kit I (Omega) and the inserts were
sequenced using M13 universal primers. PCR reactions
were carried out independently and repeated at least
twice for each fragment. Sequences were assembled
using the SeqMan II software (DNAstart Inc.).
For assessment of gene conversion at the pilE locus,
we first determined the presence of the pilE locus by
PCR with primers 5’pilE and 3’pilE, which anneal up-
stream and downstream of pilE, respectively [35]. In a
second PCR, we combined primer 5’pilE with a primer
(TTAGCTGGCATCACTTGCG) that anneals with a
hypervariable region of pilE in MC58.DNA sequence analyses
The tpsA and tpsC sequences available in the genome
sequence databases of N. meningitidis strains α14, α153,
α275 [27], 053442 [28], 8013 [29], FAM18 [2], MC58 [30],
and Z2491 [31] were used. Comparative analysis within
TPS regions was performed using Clone Manager soft-
ware. All sequences were aligned using MAFFT server
version 6 (http://align.bmr.kyushu-u.ac.jp/mafft/online/
server/). Amino-acid distances were determined by phylo-
genetic analysis using the Neighbor-joining method with
the available MEGA software version 4.0 (http://www.
megasoftware.net/).
Generation of DNA constructs and mutants
To obtain a ΔtpsA-tpsC knockout mutant, DNA frag-
ments h1, corresponding to the tpsB gene, and i, located
downstream of the TPS island, were amplified from
chromosomal DNA of strain B16B6 using the primers
listed in Additional file 3. Both PCR products were
purified, digested with proper restriction enzymes
(Additional file 3), and sequentially cloned into pUC21.
Then, a kan cassette was inserted between the cloned
fragments yielding plasmid pKOtpsA-tpsC. To obtain
the ΔtpsC2-5 mutant, DNA fragment h2, encompassing
most of tpsC2 and its upstream IORF, was amplified,
purified, and exchanged for fragment h1 on pKOtpsA-
tpsC using restriction enzymes NotI and DraIII yielding
plasmid pKOtpsC2-5. Plasmid pKO-tpsB1 [19] was used
to obtain a tpsB mutant. The knockout constructs were
purified with the plasmid extraction kit I and used to
transform [47] strain B16B6 where the target genes were
disrupted by homologous recombination. Appropriate
PCRs were used to verify the presence of the correct
mutations in kanamycin-resistant transformants and,
where appropriate, the loss of TpsA or TpsB expression
was confirmed on Western blots.
The unencapsulated mutant of serogroup B strain
B16B6, designated BB-1, was previously described [48].
Unencapsulated mutants of derivatives of B16B6 and
of serogroup C isolate 2001044 were obtained by gene
replacement as described [48]. Recombination of the
knockout constructs into the chromosome resulted in re-
placement of the complete capsule locus or only the siaD
gene by an erythromycin- or chloramphenicol-resistance
cassette, respectively. Correct mutations were verified by
appropriate PCRs. The absence of serogroup B capsule in
the B16B6 derivatives was also confirmed with monoclonal
antibody anti-MBPS [49].
For complementation experiments, DNA fragment v
corresponding to the IORF downstream of tpsA was
amplified from chromosomal DNA of strain B16B6
using the primers listed in Additional file 3: Table S3.
The PCR product was purified and cloned via NdeI and
AatII digestion into pEN11-Imp [50] to yield plasmid
Arenas et al. BMC Genomics 2013, 14:622 Page 13 of 14
http://www.biomedcentral.com/1471-2164/14/622pFPIORF1. The correct sequence of the inserted DNA
fragment was confirmed.
Electrophoresis and immunoblotting
For SDS-PAGE, 8% (w/v) polyacrylamide gels were used.
Proteins were visualized with Coomassie Brilliant Blue
G250 or transferred to nitrocellulose membranes. The
blots were incubated with blocking buffer [phosphate-
buffered saline with 0.5% (w/v) non-fat dried milk
(Protifar, Nutricia) and 0.1% (v/v) Tween 20 (Merck)].
Washes were done with blocking buffer without Protifar.
All incubations were carried out for 1 hour at room
temperature with constant shaking. After incubation
with polyclonal antiserum directed against the TPS
domain of TpsA1 [19] or NalP (anti-1669) [51] or with
monoclonal antibodies for the specific detection of OpaJ
and OpaA (15–1.P5.5) [52] or OpaD and OpaB
(MN20E12.70) [53] at working dilutions in blocking
buffer, the blots were developed with horseradish-
peroxidase-conjugated goat anti-rabbit-IgG or anti-
mouse-IgG (Biosource International) and the Pierce ECL
Western Blotting Substrate.
Growth inhibition assay
The unencapsulated derivative of strain B16B6, BB-1,
was transformed with plasmid pEN300 [51] containing a
chloramphenicol-resistance marker to be able to dis-
criminate between bacteria from co-cultures. A spontan-
eous rifampicin-resistant derivative of BB-1 was used for
the same purpose in complementation assays, where the
target cells carried a chloramphenicol-resistance marker
on plasmid pFPIORF1. Bacteria from overnight cultures
were inoculated in antibiotic-free TSB either containing
or not 0.25 mM IPTG and grown with shaking until
they reached an optical density at 600 nm of ~3. Subse-
quently, bacteria were mixed 1:1 and drops were spotted
on antibiotic-free GC medium plates either with or with-
out 0.25 mM IPTG and incubated at 37°C in candle jars
in a humid atmosphere containing ~5% CO2. After dif-
ferent time periods, the bacteria were scraped from the
plates, resuspended in TSB, and the ratio of the different
bacteria in the co-culture was determined by plating on
selective GC plates containing the appropriate antibi-
otics and overnight incubation. The numbers of viable
cells in the initial cultures were similarly determined.Additional files
Additional file 1: Supplemental information containing one
supplemental table and seven supplemental figures.
Additional file 2: Table S2. listing the meningococcal isolates used in
this study and summarizing the results of PCR and Western blot analyses.
Additional file 3: Table S3. listing the PCR primers used in this study.Abbreviations
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